Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.73 USD | +1.42% | -3.02% | -50.28% |
Financials (USD)
Sales 2024 * | 41.78M | Sales 2025 * | 125M | Capitalization | 637M |
---|---|---|---|---|---|
Net income 2024 * | -394M | Net income 2025 * | -330M | EV / Sales 2024 * | 3.2 x |
Net cash position 2024 * | 503M | Net cash position 2025 * | 330M | EV / Sales 2025 * | 2.45 x |
P/E ratio 2024 * |
-1.63
x | P/E ratio 2025 * |
-2.04
x | Employees | 487 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.53% |
Latest transcript on Sage Therapeutics, Inc.
1 day | +1.42% | ||
1 week | -3.02% | ||
Current month | -3.02% | ||
1 month | -9.45% | ||
3 months | -49.13% | ||
6 months | -46.18% | ||
Current year | -50.28% |
Managers | Title | Age | Since |
---|---|---|---|
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Kimi Iguchi
DFI | Director of Finance/CFO | 61 | 13-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Jonas
BRD | Director/Board Member | 71 | 13-08-13 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.13% | 15 M€ | -4.01% | ||
0.21% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 10.81 | +2.17% | 179 153 |
24-06-07 | 10.58 | -1.76% | 598,109 |
24-06-06 | 10.77 | -1.82% | 645,554 |
24-06-05 | 10.97 | +2.72% | 921,597 |
24-06-04 | 10.68 | -3.87% | 1,674,625 |
Delayed Quote Nasdaq, June 10, 2024 at 10:48 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.28% | 637M | |
+18.06% | 125B | |
+13.16% | 108B | |
-7.44% | 24.21B | |
+2.07% | 22.78B | |
-10.77% | 17.96B | |
-41.74% | 16.43B | |
-12.48% | 16.37B | |
+1.02% | 13.58B | |
+26.70% | 11.66B |
- Stock Market
- Equities
- SAGE Stock